Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | Interferon in polycythemia vera: long – term experience from a single center

Richard Silver • 10 Nov 2022
Texas MPN Workshop 2022
Essential Thrombocythemia Myelofibrosis Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases Interferon Ropeginterferon alfa-2a Ropeginterferon alfa-2b

Richard Silver, MD, Weill Cornell Medical College, New York, NY, gives a presentation on the long-term outcomes of interferon use in polycythemia vera (PV) at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

More from Richard Silver

3:23
The role of rusfertide in polycythemia vera
Richard Silver • 18 Oct 2022
6:49
The role of interferon in polycythemia vera & perspectives on the management of low-risk patients
Richard Silver • 18 Oct 2022
6:19
Management of patients with PV who are intolerant to interferon and who develop post-polycythemic MF
Richard Silver • 18 Oct 2022
2:50
Looking forward to the 2022 MPN Congress
Richard Silver • 18 Oct 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals